Press Release

Plasma Component Separator Market worth 8.2% CAGR by 2027

July, 2021

" Plasma Component Separator Market based on Technology, End User and Geography – Global Forecast up to 2027 "

Plasma component separators are used in the process of separation of plasma from the blood. The separation of plasma components is known as plasma fractionation. Plasma is commonly used to raise blood volume, or it can be separated into separate plasma proteins such as fibrinogen, factor VIII, anti-thrombin III, and factor IX. Plasmapheresis therapy eliminates pathogenic factors from the patient’s plasma by extracorporeal circulation. These separators and fractionators possess a hollow fiber membrane, in which desired plasma component is separated.

Rising incidences of blood cancer among individuals are a significant factor driving the growth of the plasma component separator market. Elevating demand for plasma from biopharmaceutical industries is another factor expected to drive the growth of the market. The growth in the number of plasma donors and the research and development investments of biopharmaceutical companies are also projected to have a major impact on the market. In addition, the presence of favorable government initiatives and a recovery framework is likely to increase demand for plasma component separators over the forecast period.

Request for sample copy of the report @

Furthermore, the emergence of new therapy lines such as stem cell therapy, immunoglobulin therapy, and radiotherapy for regulating & preventing chronic diseases is exceptionally bolstering the adoption of plasma component separator procedures, boosting the growth of the global plasma component separator market.

The Plasma Component Separator Market research report titled “Plasma Component Separator Market based on Technology, End User and Geography – Global Forecast up to 2027.

Key significant players operating in the plasma component separator market are Toray Medical Company Ltd, Asahi Kasei Medical Co, Ltd, B Braun Melsungen AG, Kawasumi Laboratories Inc, and Fresenius Medical Care.

North America region is leading the market. Asia Pacific region is forecasted to have lucrative growth in the coming years due to the growing incidence of blood disorders requiring plasma and platelet transfusion in the developing markets of India and China.

Access full report summary @

The report consists of 66 Tables and 45 charts depicting the in-depth market study and the impact analysis of COVID-19. View detailed TOC here.

Plasma Component Separator Market based on Technology

  • Membrane Plasma Separation technique
  • Centrifugation
  • Filtration

Plasma Component Separator Market based on End User      

  • Hospitals
  • Diagnostic laboratory
  • Pharmaceutical and Biotechnological Industry
  • Blood Banks
  • Research/ Academic Institutes

Plasma Component Separator Market based on Geography

  • North America
  • Europe
  • Asia Pacific
  • Rest of the World

Mr. Karthick Subramani

Infoholic Research LLP

Marketing & Communication